Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Capital Leases: 2020-2024

Historic Capital Leases for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Dec 2024 value amounting to $31.1 million.

  • Maravai Lifesciences Holdings' Capital Leases fell 2.94% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year decrease of 2.94%. This contributed to the annual value of $31.1 million for FY2024, which is 2.48% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Capital Leases of $31.1 million as of FY2024, which was down 2.48% from $31.9 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Capital Leases ranged from a high of $56.2 million in FY2020 and a low of $31.1 million during FY2024.
  • Over the past 2 years, Maravai Lifesciences Holdings' median Capital Leases value was $31.5 million (recorded in 2023), while the average stood at $31.5 million.
  • Data for Maravai Lifesciences Holdings' Capital Leases shows a maximum YoY fell of 2.48% (in 2024) over the last 5 years.
  • Maravai Lifesciences Holdings' Capital Leases (Yearly) stood at $56.2 million in 2020, then reached $31.9 million in 2023, then fell by 2.48% to $31.1 million in 2024.